ARCT:NASDAQ
Arcturus Therapeutics Holdings Inc
၇.၄၅ US$
arrow_downward
-၁.၉၇%(-၀.၁၅) 1D
၇.၅၅ US$
arrow_upward
+၁.၃၄% (+၀.၁၀)bedtimeAfter hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARCT...
Open
၇.၄၀ US$
High
၇.၇၃ US$
Low
၇.၃၁ US$
Mkt. cap
၂၁.၄၇ ကုဋေ
Avg. vol.
၆.၅၂ သိန်း
Volume
၆.၀၂ သိန်း
52-wk high
၁၇.၉၆ US$
52-wk low
၅.၅၀ US$
EPS
-၃.၀၈ US$
Beta
၂.၆၂
Shares outstanding
၂.၈၈ ကုဋေ
No. of employees
၁၀၉
Open
၇.၄၀ US$
High
၇.၇၃ US$
Low
၇.၃၁ US$
Mkt. cap
၂၁.၄၇ ကုဋေ
Avg. vol.
၆.၅၂ သိန်း
Volume
၆.၀၂ သိန်း
52-wk high
၁၇.၉၆ US$
52-wk low
၅.၅၀ US$
EPS
-၃.၀၈ US$
Beta
၂.၆၂
Shares outstanding
၂.၈၈ ကုဋေ
No. of employees
၁၀၉
News stories
From web sources and news partners
The Motley Fool
·
ပြီးခဲ့သည့် ၃၄ မိနစ်
If the S&P 500 Drops by 20%, I'm Buying These 3 ETFs Without Hesitation
Traders Union
·
ပြီးခဲ့သည့် ၅၃ မိနစ်
Seventeen of the twenty largest S&P 500 drops began below the 200-day moving average, Ryan Detrick notes
24/7 Wall St.
·
ပြီးခဲ့သည့် ၃၂ မိနစ်
Jim Cramer Says the Market “Sliced Right Through” His S&P 500 Target
TradingView
·
ပြီးခဲ့သည့် ၃ နာရီ
Stock Market Crash: Nasdaq, S&P 500 Suffer Worst Weekly Losses in Years
Profile
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA, messenger RNA, gene editing RNA, DNA, antisense oligonucleotides, and microRNA.
The company develops RNA therapeutics for the treatment of rare diseases such as ornithine transcarbamylase deficiency, and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19 and an influenza vaccine in the preclinical development phase. The vaccine for COVID-19 was authorised in Japan in 2023 and the European Union in 2025. Wikipedia
About Arcturus Therapeutics Holdings Inc
CEOJoseph E. Payne
Employees၁၀၉
Founded၂၀၁၃
Headquarters-
SectorHealth Care
Industry-
Websitearcturusrx.com